Dialysis Corp. of America (DCAI) Approves $3M Buyback
Dialysis Corporation of America (Nasdaq: DCAI) announced that its Board of Directors has approved a stock repurchase program, effective April 13, 2009. Under the program, the company is authorized to repurchase up to $3 million of its outstanding shares of common stock from time to time, depending on market conditions, share price and other factors.
The stock purchases will be made out of available cash in open market transactions at the prevailing market price or through privately negotiated transactions.
The stock purchases will be made out of available cash in open market transactions at the prevailing market price or through privately negotiated transactions.
You May Also Be Interested In
- JAKKS Pacific (JAKK) Announces 4M Common Tender at $20/Share
- SEI Investments (SEIC) Adds $100M to Buyback
- Riverbed (RVBD) Raises Buyback Program to $300M
Create E-mail Alert Related Categories
Stock BuybacksSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
